What is the recommended vaccination schedule for a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adult Vaccination Schedule

All adults require ongoing vaccination throughout life based on age, health conditions, occupation, and lifestyle factors, with annual influenza vaccination recommended universally and age-specific vaccines administered according to the most recent ACIP guidelines. 1, 2

Universal Vaccinations for All Adults

  • Influenza: Annual vaccination for all adults regardless of age, with high-dose or adjuvanted vaccines preferred for adults ≥65 years 2, 3
  • Tdap/Td: One dose of Tdap if not previously received, then Td or Tdap booster every 10 years 2, 4, 3
  • COVID-19: Follow current CDC recommendations for primary series and boosters (based on general medical knowledge and evolving guidelines)

Age-Specific Vaccination Recommendations

Ages 19-26 Years

  • HPV: 2-3 dose series depending on age at initial vaccination; routine recommendation through age 26 2, 3
  • MMR: 1-2 doses if born in 1957 or later without documentation of vaccination or evidence of immunity 2, 3
  • Varicella: 2 doses if born in 1980 or later without evidence of immunity 2, 3
  • Meningococcal B (MenB): 2-3 doses depending on vaccine, particularly for ages 19-23 years 3

Ages 27-49 Years

  • HPV: Shared clinical decision-making for vaccination ages 27-45 years 2, 3
  • Hepatitis A: 2-3 dose series for adults at risk 2, 3
  • Hepatitis B: 2-3 dose series for adults at risk (Heplisav-B: 2 doses at least 4 weeks apart; Engerix-B or Recombivax HB: 3 doses at 0,1,6 months) 2, 3

Ages 50-64 Years

  • Zoster (Shingles): 2 doses of recombinant zoster vaccine (RZV/Shingrix, preferred) given 2-6 months apart starting at age 50 2, 4, 3

Ages ≥65 Years

  • Pneumococcal:
    • PCV13 based on shared clinical decision-making 2, 3
    • PPSV23 recommended for all adults ≥65 years 2, 3
    • Prevnar 20 (PCV20) administered as a single dose is an alternative option 5
  • Zoster: 2 doses of RZV if not previously vaccinated 2, 3
  • Influenza: High-dose or adjuvanted vaccines preferred 2

Special Population Recommendations

Pregnancy

  • Tdap: One dose during each pregnancy, preferably at 27-36 weeks gestation, regardless of interval since prior Td or Tdap 1, 4, 3
  • Influenza: Annual vaccination recommended during any trimester 3
  • Live vaccines contraindicated: MMR, varicella, LAIV, zoster live vaccine 3

Healthcare Personnel

  • MMR: 1-2 doses if born in 1957 or later 1, 4
  • Varicella: 2 doses without evidence of immunity 1, 4
  • Hepatitis B: Complete series if not previously vaccinated 1, 3
  • Annual influenza: Inactivated vaccine preferred for those caring for severely immunocompromised patients 3
  • Tdap: If not previously received 1

Immunocompromised Individuals

  • Live vaccines generally contraindicated: MMR, varicella, LAIV, zoster live vaccine 2, 3
  • Pneumococcal: Both PCV13 and PPSV23 recommended with specific timing 2, 3
  • MenACWY: 2-dose primary series for adults with HIV 2
  • Hepatitis B: May require higher doses or additional doses; special formulation (40 µg/mL Recombivax HB or 2 doses of 20 µg/mL Engerix-B) for hemodialysis patients 3
  • Haemophilus influenzae type b (Hib): 3-dose series for hematopoietic stem cell transplant recipients starting 6-12 months post-transplant 3

Chronic Medical Conditions

Chronic liver disease (including hepatitis C, cirrhosis, fatty liver disease, alcoholic liver disease):

  • Hepatitis A: 2-3 dose series 2, 3
  • Hepatitis B: Complete series 2, 3

Chronic heart or lung disease, diabetes, alcoholism:

  • Pneumococcal vaccination: PCV13 and PPSV23 based on age and specific conditions 2, 3
  • Annual influenza vaccination 3

Asplenia or complement deficiencies:

  • Pneumococcal: Both PCV13 and PPSV23 3
  • MenACWY: 2-dose series with boosters 3
  • MenB: 2-3 dose series 3
  • Hib: 1 dose if not previously received, preferably ≥14 days before elective splenectomy 3

Risk-Based Vaccinations

Hepatitis A Indications

  • Chronic liver disease 3
  • Men who have sex with men 3
  • Persons who use injection or non-injection drugs 3
  • Persons with clotting factor disorders 3
  • Travel to countries with high or intermediate hepatitis A endemicity 3
  • Close personal contact with international adoptees from endemic countries 3

Hepatitis B Indications

  • End-stage renal disease/hemodialysis 3
  • HIV infection 3
  • Chronic liver disease 2
  • Healthcare personnel and public safety workers with blood exposure 3
  • Sexually active persons not in mutually monogamous relationships 3
  • Persons seeking STD evaluation or treatment 3
  • Current or recent injection drug users 3
  • Men who have sex with men 3
  • Household contacts/sex partners of HBsAg-positive persons 3
  • International travelers to endemic areas 3

Meningococcal Indications

  • Anatomical or functional asplenia 3
  • Persistent complement component deficiency 3
  • HIV infection 2
  • Eculizumab use 3
  • Microbiologists routinely exposed to Neisseria meningitidis 3
  • Travel to or residence in hyperendemic areas 3
  • College students living in residence halls 3

Important Clinical Considerations

Vaccine Series Completion

  • Vaccine series never need to be restarted regardless of time elapsed between doses 1, 4, 2
  • Minimum intervals between doses must be respected, but longer intervals do not reduce final antibody response 1

Simultaneous Administration

  • All indicated vaccines can and should be administered simultaneously at the same visit to improve completion rates 1, 4
  • Do not mix different vaccines in the same syringe 5

Evidence of Immunity

For measles, mumps, rubella:

  • Born before 1957 (except healthcare personnel and pregnant women) 3, 4
  • Documentation of vaccination 3
  • Laboratory evidence of immunity 3
  • Provider-diagnosed disease is NOT acceptable evidence 3

For varicella:

  • Documentation of 2 doses of vaccine at least 4 weeks apart 3
  • U.S.-born before 1980 (except healthcare personnel and pregnant women) 3
  • History of varicella or herpes zoster verified by healthcare provider 3
  • Laboratory evidence of immunity 3

Common Pitfalls to Avoid

  • Not checking vaccination history: Leads to missed opportunities for vaccination 4
  • Assuming immunity without documentation: Always verify with records or laboratory evidence, especially for healthcare workers 4
  • Overlooking Tdap in adults: Many adults have only received Td boosters and need one Tdap dose 4
  • Delaying simultaneous vaccine administration: Multiple vaccines can safely be given at the same visit 1, 4
  • Restarting vaccine series unnecessarily: Continue where left off regardless of time elapsed 1, 4, 2
  • Missing pregnancy-related vaccinations: Tdap should be given during EACH pregnancy 1, 4
  • Failing to consider occupation and travel: These factors significantly impact vaccination needs 4
  • Using live vaccines in immunocompromised patients: Contraindicated and potentially dangerous 2, 3

References

Guideline

Vaccination Schedule Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Adult Immunization Schedule Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vaccination Recommendations for Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.